Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
about
Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityAntimetastatic activity of a cyclooxygenase-2 inhibitorCyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancerAspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cellsCyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.Fatty acid oxidation and signaling in apoptosis.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Eicosanoids in inflammation and cancer: the role of COX-2.Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.Anti-apoptotic effects of arachidonic acid and prostaglandin E2 in pancreatic beta-cells.A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway.Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line.Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemopreventionThe anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2.Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.Differential growth inhibition and induction of apoptosis by gossypol between HCT116 and HCT116/Bax(-/-) colorectal cancer cells.Inhibition of cyclooxygenase-2 sensitizes lung cancer cells to radiation-induced apoptosis.Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides
P2860
Q24550932-23A1CB2D-2060-436E-BA1E-7C177F6042EAQ24800010-CE232D16-9E77-4962-A6BD-745A910D0EEBQ28166312-9085D59A-3492-4DCB-9D3D-F84A50A2C90AQ28169082-87F1D6AF-014E-4B4B-95C0-C5090D4D474CQ28193375-9CD94EF0-5E29-419B-8124-6ECBB33DF8D1Q28194712-AF05ADB8-AB94-4F6B-8D6E-B92CA03F16CBQ34201207-32EB8CFB-BA59-45E1-AEFE-5ED0D32958A7Q34658888-45766D25-B266-438D-8046-C465EB24068FQ35011895-F654E4C4-D20B-4F0F-BB99-38F4DAB95DABQ35670438-105886C2-EA24-483E-8B6A-12F840551EA1Q37253055-1438D0FF-CB44-47D2-8EAB-3DBD6A3D5CAEQ37646513-EEDB37D7-8E0D-4426-9CA6-B6E8173FD853Q37754720-549ADE2B-DA6F-4C23-A196-710FCACB463FQ39732523-EC0ABCC5-0A9B-4160-846C-CC051C3787E0Q40086787-7D1D8F3B-7B4E-436F-A948-1EE66CDB77D6Q40203642-20F3EA9D-CDC6-4284-8256-8A023AD80217Q40305196-90DCFC4E-C32F-4084-BAF1-2FADE8507E21Q40397960-12B1B8CE-A4BD-41A0-9218-AC5D51D9D968Q40474619-6AEB59D9-8E86-4FF8-8D08-309023472537Q40539317-03E69E5C-7B91-4F93-BCBD-295B1B4C896BQ40624888-93CD634D-89E8-4E15-BED5-E81FBCCBCE69Q40753311-C28FB0A4-301F-46CC-8981-D8D45A63DF4EQ42017681-E700EFEB-1772-4876-AEB2-992AB5DB0CBFQ42157330-F4AB9567-5A97-4CAE-A5AC-1CF3BA834DA0Q42269301-B8C56162-F166-4D22-A7BD-413CA104E0FAQ44902049-CE96132D-3AA1-4236-B830-4769FF892044Q44926501-EC454D05-A01D-4247-B8D9-094BF65B7668Q47141515-E2629C5E-1883-4CDB-B515-FF557D6CD9E4Q57822075-527BF692-ED34-4C48-9798-E0CE9B6FDD0C
P2860
Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Induction of apoptosis by cycl ...... ay in esophageal cancer cells.
@en
type
label
Induction of apoptosis by cycl ...... ay in esophageal cancer cells.
@en
prefLabel
Induction of apoptosis by cycl ...... ay in esophageal cancer cells.
@en
P2093
P2860
P356
P1476
Induction of apoptosis by cycl ...... ay in esophageal cancer cells.
@en
P2093
P2860
P304
P356
10.1002/IJC.1322
P577
2001-07-01T00:00:00Z